KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fulgent Genetics (FLGT) Change in Account Payables (2016 - 2025)

Historic Change in Account Payables for Fulgent Genetics (FLGT) over the last 11 years, with Q3 2025 value amounting to -$102000.0.

  • Fulgent Genetics' Change in Account Payables fell 10447.76% to -$102000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.2 million, marking a year-over-year decrease of 12952.79%. This contributed to the annual value of $3.1 million for FY2024, which is 14446.06% up from last year.
  • As of Q3 2025, Fulgent Genetics' Change in Account Payables stood at -$102000.0, which was down 10447.76% from $386000.0 recorded in Q2 2025.
  • In the past 5 years, Fulgent Genetics' Change in Account Payables registered a high of $7.0 million during Q4 2022, and its lowest value of -$22.1 million during Q3 2022.
  • In the last 5 years, Fulgent Genetics' Change in Account Payables had a median value of -$658000.0 in 2025 and averaged -$2.2 million.
  • The largest annual percentage gain for Fulgent Genetics' Change in Account Payables in the last 5 years was 31822.72% (2022), contrasted with its biggest fall of 186020.73% (2022).
  • Fulgent Genetics' Change in Account Payables (Quarter) stood at -$3.2 million in 2021, then skyrocketed by 318.23% to $7.0 million in 2022, then crashed by 98.16% to $129000.0 in 2023, then tumbled by 726.36% to -$808000.0 in 2024, then skyrocketed by 87.38% to -$102000.0 in 2025.
  • Its Change in Account Payables was -$102000.0 in Q3 2025, compared to $386000.0 in Q2 2025 and -$658000.0 in Q1 2025.